Legal Representation
Attorney
Yue (Robert) Xu
USPTO Deadlines
Next Deadline
1087 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20190122)
Due Date
January 22, 2029
Grace Period Ends
July 22, 2029
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 14, 2025 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Jan 14, 2025 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Nov 27, 2024 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| May 31, 2024 | PUM1 | O | OFFICE ACTION ISSUED POU1 | Loading... |
| May 30, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Mar 13, 2024 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Jan 22, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 22, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 13, 2018 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Dec 13, 2018 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Dec 13, 2018 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| May 31, 2017 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Mar 2, 2017 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jan 31, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 31, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 11, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 18, 2016 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 18, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 15, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 15, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Allergy tablets; Antiallergic medicines; Antibiotic preparations; Antibiotic tablets; Chemical preparations for pharmaceutical or medical purposes, namely, for use in dermatology, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity; Dietary supplements; Dietetic foods, namely, pasta and crackers adapted for medical use; Enzyme dietary supplements; Enzymes for medical purposes; Enzymes for veterinary purposes; Nutritional supplements; Preparations for destroying noxious animals; Sterilising preparations; Sulphonamides as medicines; Vitamin tablets; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets
First Use Anywhere:
Jan 24, 1998
First Use in Commerce:
Apr 13, 2007
Additional Information
Design Mark
The mark consists of the stylized wording "ZMC".
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "ZMC" has no meaning in a foreign language.
Classification
International Classes
005